Dual effect of p53 on radiation sensitivity in vivo:: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice

被引:191
作者
Komarova, EA
Kondratov, RV
Wang, KH
Christov, K
Golovkina, TV
Goldblum, JR
Gudkov, AV
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, Cleveland, OH 44195 USA
[2] Quark Biotech Inc, Cleveland, OH 44195 USA
[3] Univ Illinois, Dept Surg Oncol, Chicago, IL 60612 USA
[4] Jackson Lab, Bar Harbor, ME 04609 USA
[5] Cleveland Clin Fdn, Dept Anat Pathol, Cleveland, OH 44195 USA
关键词
p53; radiation; hematopoietic syndrome; gastro-intestinal syndrome; apoptosis; growth arrest;
D O I
10.1038/sj.onc.1207494
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ionizing radiation (IR) induces p53-dependent apoptosis in radiosensitive tissues, suggesting that p53 is a determinant of radiation syndromes. In fact, p53-deficient mice survive doses of IR that cause lethal hematopoietic syndrome in wild-type animals. Surprisingly, p53 deficiency results in sensitization of mice to higher doses of IR, causing lethal gastro-intestinal (GI) syndrome. While cells in the crypts of p53-wild-type epithelium undergo prolonged growth arrest after irradiation, continuous cell proliferation ongoing in p53-deficient epithelium correlates with accelerated death of damaged cells followed by rapid destruction of villi and accelerated lethality. p21-deficient mice are also characterized by increased sensitivity to GI syndrome-inducing doses of IR. We conclude that p53/p21-mediated growth arrest plays a protective role in the epithelium of small intestine after severe doses of IR. Pharmacological inhibition of p53 by a small molecule that can rescue from lethal hematopoietic syndrome has no effect on the lethality from gastro-intestinal syndrome, presumably because of a temporary and reversible nature of its action.
引用
收藏
页码:3265 / 3271
页数:7
相关论文
共 27 条
[1]   Crowd control in the crypt [J].
Booth, C ;
Brady, G ;
Potten, CS .
NATURE MEDICINE, 2002, 8 (12) :1360-+
[2]  
Botchkarev VA, 2000, CANCER RES, V60, P5002
[3]  
Cai WB, 1997, INT J RADIAT BIOL, V71, P145, DOI 10.1080/095530097144265
[4]  
Cui Y. F., 1995, Journal of Environmental Pathology Toxicology and Oncology, V14, P159
[5]   A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β-peptide [J].
Culmsee, C ;
Zhu, XX ;
Yu, QS ;
Chan, SL ;
Camandola, S ;
Guo, ZH ;
Greig, NH ;
Mattson, MP .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (01) :220-228
[6]   p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism [J].
Duan, WZ ;
Zhu, XX ;
Ladenheim, B ;
Yu, QS ;
Guo, ZH ;
Oyler, J ;
Cutler, RG ;
Cadet, JL ;
Greig, NH ;
Mattson, MP .
ANNALS OF NEUROLOGY, 2002, 52 (05) :597-606
[7]   The role of p53 in determining sensitivity to radiotherapy [J].
Gudkov, AV ;
Komarova, EA .
NATURE REVIEWS CANCER, 2003, 3 (02) :117-129
[8]   p53 deficiency sensitizes clonogenic cells to irradiation in the large but not the small intestine [J].
Hendry, JH ;
Cai, WB ;
Roberts, SA ;
Potten, CS .
RADIATION RESEARCH, 1997, 148 (03) :254-259
[9]   A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy [J].
Komarov, PG ;
Komarova, EA ;
Kondratov, RV ;
Christov-Tselkov, K ;
Coon, JS ;
Chernov, MV ;
Gudkov, AV .
SCIENCE, 1999, 285 (5434) :1733-1737
[10]   Could p53 be a target for therapeutic suppression? [J].
Komarova, EA ;
Gudkov, AV .
SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) :389-400